Athira Pharma, Inc.

Athira Pharma, Inc. - Current Ratioverified

ATHA

Price:

$6.75

Market Cap:

$32.26M

Athira Pharma, Inc., a biopharmaceutical firm in advanced clinical development and based in Bothell, Washington, focuses on creating small molecule treatments designed to revitalize neuronal function and decelerate neurological decline. Its primary therapeutic candidate, ATH-1017, is a unique small molecule that modulates HGF/MET and is capable of crossing the blood-brain barrier. This compound is currently undergoing a Phase 3 clinical trial (LIFT-AD) and a Phase 2 clinical trial (ACT-AD) for Alzheimer's disease. Additionally, ATH-1017 is in Phase 2 clinical trials for Parkinson's disease. The company also has several product candidates in earlier, preclinical stages of development, includi...[Read more]

Industry

Biotechnology

IPO Date

2020-09-18

Stock Exchange

NASDAQ

Ticker

ATHA

The Current Ratio as of June 2026 (TTM) for Athira Pharma, Inc. (ATHA) is 10.38

According to Athira Pharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.38. This represents a change of 26.72% compared to the average of 8.19 of the last 4 quarters.

Athira Pharma, Inc. (ATHA) Historical Current Ratio (quarterly & annually)

How has ATHA Current Ratio performed in the past?

The mean historical Current Ratio of Athira Pharma, Inc. over the last ten years is 12.89. The current 10.38 Current Ratio has changed 7.96% with respect to the historical average. Over the past ten years (40 quarters), ATHA's Current Ratio was at its highest in in the March 2021 quarter at 69.28. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

12.89

Median

6.96

Minimum

1.70

Maximum

43.66

Athira Pharma, Inc. (ATHA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Athira Pharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.47%

Maximum Annual Current Ratio = 43.66

Minimum Annual Increase = -80.18%

Minimum Annual Current Ratio = 1.70

Quarterly (TTM)
Annual
YearCurrent RatioChange
20251.88-54.90%
20244.18-22.18%
20235.37-44.60%
20229.68-65.50%
202128.07-35.72%
202043.662.47%
20191.70-80.18%

Athira Pharma, Inc. (ATHA) Average Current Ratio

How has ATHA Current Ratio performed in the past?

The current Current Ratio of Athira Pharma, Inc. (ATHA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

3.81

5-year avg

9.83

10-year avg

12.89

Athira Pharma, Inc. (ATHA) Current Ratio vs. Peers

How is ATHA’s Current Ratio compared to its peers?

Athira Pharma, Inc.’s Current Ratio is less than Leap Therapeutics, Inc. (27.28), greater than Citius Pharmaceuticals, Inc. (0.58), greater than SeaStar Medical Holding Corporation (2.73), greater than Apollomics, Inc. (0.96), greater than Moleculin Biotech, Inc. (1.38), greater than Curis, Inc. (1.00), greater than FibroBiologics, Inc. Common Stock (1.59), greater than Lunai Bioworks Inc. (0.19), greater than Aditxt, Inc. (0.06), greater than Daré Bioscience, Inc. (1.03),

Build a custom stock screener for Athira Pharma, Inc. (ATHA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Athira Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Athira Pharma, Inc. (ATHA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Athira Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Athira Pharma, Inc.'s Current Ratio?

How is the Current Ratio calculated for Athira Pharma, Inc. (ATHA)?

What is the highest Current Ratio for Athira Pharma, Inc. (ATHA)?

What is the 3-year average Current Ratio for Athira Pharma, Inc. (ATHA)?

What is the 5-year average Current Ratio for Athira Pharma, Inc. (ATHA)?

How does the current Current Ratio for Athira Pharma, Inc. (ATHA) compare to its historical average?